EW
GILD icon

Elyxium Wealth’s Gilead Sciences GILD Stock Holding History

Elyxium Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Buy
3,502
+1,041
+42% +$137K 0.05% 188
2026
Q1 		$343K Sell
2,461
-862
-26% -$121K 0.11% 119
2025
Q4 		$408K Buy
3,323
+151
+5% +$18.4K 0.11% 119
2025
Q3 		$352K Buy
3,172
+52
+2% +$5.91K 0.12% 125
2025
Q2 		$346K Buy
3,120
+203
+7% +$21.6K 0.13% 125
2025
Q1 		$327K Buy
+2,917
New +$301K 0.14% 116

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Elyxium Wealth's GILD Position: Q2 2026 in Review

Elyxium Wealth increased its Gilead Sciences (GILD) stake by 42% in Q2 2026, buying an estimated $137K and bringing the position to 3,502 shares worth $442K. The position accounts for 0.05% of the portfolio, ranked #188.

Elyxium Wealth first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Elyxium Wealth held 3,502 shares of Gilead Sciences worth $442K as of Q2 2026.
  • Elyxium Wealth bought 1,041 Gilead Sciences shares in Q2 2026, an estimated $137K.
  • Gilead Sciences made up 0.05% of Elyxium Wealth's portfolio in Q2 2026, its #188 holding.
  • Elyxium Wealth first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Elyxium Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.